Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![$crvs Graphic](https://lunarcrush.com/gi/w:26/t:$crvs.png) $crvs

Novo Nordisk executive joins $CRVS board, sparking positive sentiment. Barclays initiates coverage on $CRVS with an Overweight rating and a $XX price target.

### About $crvs
Curve DAO Token ($CRVS) is a cryptocurrency.  

### Insights [#](/topic/$crvs/insights)
- $crvs engagements is up XXXXXX% from the previous week.
- $crvs posts created is up XXXXXX% from the previous week.

### Engagements: XXXXXX [#](/topic/$crvs/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$crvs/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$crvs/time-series/interactions.tsv)  
**Current Value**: XXXXXX  
**Daily Average**: XXXXXX  
**1 Week**: XXXXXXX +360%  
**1 Month**: XXXXXXX -XX%  
**6 Months**: XXXXXXXXX +527%  
**1-Year High**: XXXXXXX on 2025-05-13  
**1-Year Low**: XX on 2025-01-26  

| Social Network | X      |
| -------------- | -      |
| Engagements    | XXXXXX |
  

  
  
### Mentions: XXX [#](/topic/$crvs/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$crvs/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$crvs/time-series/posts_active.tsv)  
**Current Value**: XXX  
**Daily Average**: XX  
**1-Year High**: XXX on 2025-01-24  
**1-Year Low**: XX on 2025-09-15  

| Social Network | X   |
| -------------- | -   |
| Mentions       | XXX |
  

  
  
### Creators: XX [#](/topic/$crvs/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$crvs/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$crvs/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning $crvs in the last XX hours which is up XX% from XX in the previous XX hours
**Daily Average**: XX  
**1-Year High**: XXX on 2025-06-27  
**1-Year Low**: X on 2025-01-12  

The most influential creators that mention $crvs in the last XX hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@HOThomasWPhelps](/creator/twitter/HOThomasWPhelps) | X    | XXXXX     | XX    | XXXXX       |
| [@semodough](/creator/twitter/semodough)             | X    | XXXXXX    | XX    | XXXXX       |
| [@JamesEKrause](/creator/twitter/JamesEKrause)       | X    | XXXXXX    | X     | XXXXX       |
| [@tradingsssss](/creator/twitter/tradingsssss)       | X    | XXX       | XX    | XXXXX       |
| [@thegunnerab](/creator/twitter/thegunnerab)         | X    | XXXXX     | X     | XXXXX       |
| [@FL0WG0D](/creator/twitter/FL0WG0D)                 | X    | XXXXXX    | X     | XXX         |
| [@RybeccaSmith33](/creator/twitter/RybeccaSmith33)   | X    | XXX       | X     | XXX         |
| [@OmniTradeA1](/creator/twitter/OmniTradeA1)         | X    | XXXXX     | X     | XXX         |
| [@CHItraders](/creator/twitter/CHItraders)           | X    | XXXXX     | X     | XXX         |
| [@PocketsAbyss](/creator/twitter/PocketsAbyss)       | XX   | XXX       | X     | XXX         |

[View More](/list/creators/$crvs/100)
  
  
### Sentiment: XX% [#](/topic/$crvs/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$crvs/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$crvs/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% -X%  
**1 Month**: XX% -X%  
**6 Months**: XX% +15%  
**1-Year High**: XXX% on 2025-01-10  
**1-Year Low**: XX% on 2025-01-24  

**Most Supportive Themes**
- **DeFi and Cross-Chain Potential:** (40%) Discussions around $CRVS's potential in the DeFi market and its growth, especially with cross-chain platforms.
- **Biopharma and Biotech Catalysts:** (30%) Positive developments in the biopharma sector, including discussions around $CRVS and its potential in autoimmune drug targets.
  
**Most Critical Themes**
- **Competition and Market Dynamics:** (10%)  Posts discussing the competitive landscape and how it may affect the market.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXXXX    | XX% | XXXXXX  | XX% | XXX      | X% |
|         |          |     |         |     |          |    |
| Total   | XXXXX    | XX% | XXXXXX  | XX% | XXX      | X% |
  


**Top assets mentioned**
In the posts about $crvs in the last XX hours

[Kymera Therapeutics, Inc. Common Stock (KYMR)](/topic/$kymr)
[Apogee Therapeutics, Inc. Common Stock (APGE)](/topic/$apge)
[Protagonist Therapeutics, Inc (PTGX)](/topic/$ptgx)
[Sanofi (SNY)](/topic/sanofi)
[Apple, Inc. (AAPL)](/topic/$aapl)
[Novo-Nordisk (NVO)](/topic/$nvo)
[Regeneron Pharmaceuticals Inc (REGN)](/topic/regeneron-pharmaceuticals-inc)
[Bitcoin Incognito (XBI)](/topic/$xbi)
[Synthetify (SNY)](/topic/$sny)
[Celldex Therapeutics, Inc (CLDX)](/topic/$cldx)

**Top topics mentioned**
In the posts about $crvs in the last XX hours

[$ocgn](/topic/$ocgn), [$efa](/topic/$efa), [stocks technology](/topic/stocks-technology), [discord](/topic/discord), [$nktr](/topic/$nktr), [stocks healthcare](/topic/stocks-healthcare), [stocks energy](/topic/stocks-energy), [$abvx](/topic/$abvx), [$barcl](/topic/$barcl), [$kymr](/topic/$kymr), [$apge](/topic/$apge), [stocks](/topic/stocks), [$clov](/topic/$clov), [$anab](/topic/$anab), [$ptgx](/topic/$ptgx), [sanofi](/topic/sanofi), [$aapl](/topic/$aapl), [$nvo](/topic/$nvo), [$pali](/topic/$pali), [stocks bitcoin treasuries](/topic/stocks-bitcoin-treasuries), [regeneron pharmaceuticals inc](/topic/regeneron-pharmaceuticals-inc), [$xbi](/topic/$xbi), [coins bitcoin ecosystem](/topic/coins-bitcoin-ecosystem), [$sny](/topic/$sny), [$novcde](/topic/$novcde), [$cldx](/topic/$cldx), [$acrs](/topic/$acrs), [$500m](/topic/$500m), [stocks real estate](/topic/stocks-real-estate), [$14b](/topic/$14b), [$28bn](/topic/$28bn), [bitcoin](/topic/bitcoin), [coins layer 1](/topic/coins-layer-1), [coins pow](/topic/coins-pow), [coins defi](/topic/coins-defi), [coins base ecosystem](/topic/coins-base-ecosystem), [$mngl](/topic/$mngl), [novo](/topic/novo), [investment](/topic/investment), [eli lilly](/topic/eli-lilly), [$lly](/topic/$lly), [approved](/topic/approved), [$qure](/topic/$qure), [$1b](/topic/$1b), [number of](/topic/number-of), [$bbio](/topic/$bbio), [$crv](/topic/$crv), [coins exchange tokens](/topic/coins-exchange-tokens), [coins dao](/topic/coins-dao), [momentum](/topic/momentum), [$mdgl](/topic/$mdgl), [$rna](/topic/$rna), [$idya](/topic/$idya), [long term](/topic/long-term), [targets](/topic/targets), [$abcl](/topic/$abcl), [market cap](/topic/market-cap), [atai life](/topic/atai-life), [$35b](/topic/$35b), [asset management](/topic/asset-management), [$9211b](/topic/$9211b), [$8362b](/topic/$8362b), [blackrock](/topic/blackrock), [stocks financial services](/topic/stocks-financial-services), [vivo](/topic/vivo), [nov inc](/topic/nov-inc), [investments](/topic/investments), [$psnl](/topic/$psnl), [coins meme](/topic/coins-meme), [$dc](/topic/$dc), [lobothewolfpup](/topic/lobothewolfpup), [coins runes](/topic/coins-runes), [$77k](/topic/$77k), [im a](/topic/im-a), [$bmy](/topic/$bmy), [$5b](/topic/$5b), [$26b](/topic/$26b), [tesla](/topic/tesla), [united states dollar](/topic/united-states-dollar), [$37k](/topic/$37k), [$open](/topic/$open), [printing](/topic/printing), [$reymi](/topic/$reymi), [$8m](/topic/$8m), [$28m](/topic/$28m), [$15b](/topic/$15b), [has been](/topic/has-been), [dawn](/topic/dawn), [dec](/topic/dec), [candle](/topic/candle), [$nxtt](/topic/$nxtt), [next technology holding](/topic/next-technology-holding), [coins](/topic/coins), [$nvve](/topic/$nvve), [roman](/topic/roman), [$rcus](/topic/$rcus), [all the](/topic/all-the), [$lrmr](/topic/$lrmr), [$unh](/topic/$unh), [$lulu](/topic/$lulu)

### Top Social Posts [#](/topic/$crvs/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Best discord group for the traders join hereπŸ””πŸ’°πŸ’°πŸ‘‡βœ”βœ” $OCGN $EFA $COP $SHIP $XOP $APA $BB $PTON $KRE $HPE $GTE $ZNGA $CRVS"  
[X Link](https://x.com/Rahul04980546/status/1979321522092413100) [@Rahul04980546](/creator/x/Rahul04980546) 2025-10-17T22:59Z XXX followers, XXX engagements


"Exercise patience with $CLOV. We're faced with a decision: hold or sell $CLOV. It's up to you to decide $OCGN $EFA $COP $SHIP $XOP $AAPL $APA $BB $PTON $QQQ $KRE $HPE $GTE $ZNGA $CRVS"  
[X Link](https://x.com/Rahul04980546/status/1979281161407836527) [@Rahul04980546](/creator/x/Rahul04980546) 2025-10-17T20:19Z XXX followers, XXX engagements


"$CRVS -XXXX% today as Corvus Pharmaceuticals Announces Presentation of Interim Data from the Phase 1b/2 Clinical Trial of Ciforadenant for Patients with Metastatic Renal Cell Cancer at the European Society for Medical Oncology (ESMO) Congress 2025 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1979254178993066188) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T18:32Z 2801 followers, XXX engagements


"$CRVS according to chart the MACD has converged and the selling appears to have slowed and buyers could be returning.short term charting . .not investment advise. jmho"  
[X Link](https://x.com/STvrosb/status/1979236777090003429) [@STvrosb](/creator/x/STvrosb) 2025-10-17T17:23Z XXX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$crvs Graphic $crvs

Novo Nordisk executive joins $CRVS board, sparking positive sentiment. Barclays initiates coverage on $CRVS with an Overweight rating and a $XX price target.

About $crvs

Curve DAO Token ($CRVS) is a cryptocurrency.

Insights #

  • $crvs engagements is up XXXXXX% from the previous week.
  • $crvs posts created is up XXXXXX% from the previous week.

Engagements: XXXXXX #


Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXXX
Daily Average: XXXXXX
1 Week: XXXXXXX +360%
1 Month: XXXXXXX -XX%
6 Months: XXXXXXXXX +527%
1-Year High: XXXXXXX on 2025-05-13
1-Year Low: XX on 2025-01-26

Social Network X
Engagements XXXXXX

Mentions: XXX #


Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XX
1-Year High: XXX on 2025-01-24
1-Year Low: XX on 2025-09-15

Social Network X
Mentions XXX

Creators: XX #


Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning $crvs in the last XX hours which is up XX% from XX in the previous XX hours Daily Average: XX
1-Year High: XXX on 2025-06-27
1-Year Low: X on 2025-01-12

The most influential creators that mention $crvs in the last XX hours

Creator Rank Followers Posts Engagements
@HOThomasWPhelps X XXXXX XX XXXXX
@semodough X XXXXXX XX XXXXX
@JamesEKrause X XXXXXX X XXXXX
@tradingsssss X XXX XX XXXXX
@thegunnerab X XXXXX X XXXXX
@FL0WG0D X XXXXXX X XXX
@RybeccaSmith33 X XXX X XXX
@OmniTradeA1 X XXXXX X XXX
@CHItraders X XXXXX X XXX
@PocketsAbyss XX XXX X XXX

View More

Sentiment: XX% #


Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% -X%
1 Month: XX% -X%
6 Months: XX% +15%
1-Year High: XXX% on 2025-01-10
1-Year Low: XX% on 2025-01-24

Most Supportive Themes

  • DeFi and Cross-Chain Potential: (40%) Discussions around $CRVS's potential in the DeFi market and its growth, especially with cross-chain platforms.
  • Biopharma and Biotech Catalysts: (30%) Positive developments in the biopharma sector, including discussions around $CRVS and its potential in autoimmune drug targets.

Most Critical Themes

  • Competition and Market Dynamics: (10%) Posts discussing the competitive landscape and how it may affect the market.

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XXXXX XX% XXXXXX XX% XXX X%
Total XXXXX XX% XXXXXX XX% XXX X%

Top assets mentioned In the posts about $crvs in the last XX hours

Kymera Therapeutics, Inc. Common Stock (KYMR) Apogee Therapeutics, Inc. Common Stock (APGE) Protagonist Therapeutics, Inc (PTGX) Sanofi (SNY) Apple, Inc. (AAPL) Novo-Nordisk (NVO) Regeneron Pharmaceuticals Inc (REGN) Bitcoin Incognito (XBI) Synthetify (SNY) Celldex Therapeutics, Inc (CLDX)

Top topics mentioned In the posts about $crvs in the last XX hours

$ocgn, $efa, stocks technology, discord, $nktr, stocks healthcare, stocks energy, $abvx, $barcl, $kymr, $apge, stocks, $clov, $anab, $ptgx, sanofi, $aapl, $nvo, $pali, stocks bitcoin treasuries, regeneron pharmaceuticals inc, $xbi, coins bitcoin ecosystem, $sny, $novcde, $cldx, $acrs, $500m, stocks real estate, $14b, $28bn, bitcoin, coins layer 1, coins pow, coins defi, coins base ecosystem, $mngl, novo, investment, eli lilly, $lly, approved, $qure, $1b, number of, $bbio, $crv, coins exchange tokens, coins dao, momentum, $mdgl, $rna, $idya, long term, targets, $abcl, market cap, atai life, $35b, asset management, $9211b, $8362b, blackrock, stocks financial services, vivo, nov inc, investments, $psnl, coins meme, $dc, lobothewolfpup, coins runes, $77k, im a, $bmy, $5b, $26b, tesla, united states dollar, $37k, $open, printing, $reymi, $8m, $28m, $15b, has been, dawn, dec, candle, $nxtt, next technology holding, coins, $nvve, roman, $rcus, all the, $lrmr, $unh, $lulu

Top Social Posts #


Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"Best discord group for the traders join hereπŸ””πŸ’°πŸ’°πŸ‘‡βœ”βœ” $OCGN $EFA $COP $SHIP $XOP $APA $BB $PTON $KRE $HPE $GTE $ZNGA $CRVS"
X Link @Rahul04980546 2025-10-17T22:59Z XXX followers, XXX engagements

"Exercise patience with $CLOV. We're faced with a decision: hold or sell $CLOV. It's up to you to decide $OCGN $EFA $COP $SHIP $XOP $AAPL $APA $BB $PTON $QQQ $KRE $HPE $GTE $ZNGA $CRVS"
X Link @Rahul04980546 2025-10-17T20:19Z XXX followers, XXX engagements

"$CRVS -XXXX% today as Corvus Pharmaceuticals Announces Presentation of Interim Data from the Phase 1b/2 Clinical Trial of Ciforadenant for Patients with Metastatic Renal Cell Cancer at the European Society for Medical Oncology (ESMO) Congress 2025 More Info:"
X Link @OzmosiHealth 2025-10-17T18:32Z 2801 followers, XXX engagements

"$CRVS according to chart the MACD has converged and the selling appears to have slowed and buyers could be returning.short term charting . .not investment advise. jmho"
X Link @STvrosb 2025-10-17T17:23Z XXX followers, XXX engagements

$crvs
/topic/$crvs